Éva Compérat
Impact in
- Surgery top 0.02%
- Bladder and Urothelial Cancer Treatments
- Urinary and Genital Oncology Studies
- Genital Health and Disease
- Pulmonary and Respiratory Medicine top 0.2%
- Renal cell carcinoma treatment
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
Papers in
- Surgery 253
- Bladder and Urothelial Cancer Treatments 210
- Urinary and Genital Oncology Studies 23
- Testicular diseases and treatments 15
- Genital Health and Disease 12
-
- Prostate Cancer Diagnosis and Treatment 105
- Renal cell carcinoma treatment 65
- Prostate Cancer Treatment and Research 40
- Co-authors
- Morgan Rouprêt A (135 shared papers)Shahrokh François Shariat (60 shared papers)Bas W.G. van Rhijn (17 shared papers)Richard J Sylvester (17 shared papers)Marek Babjuk (18 shared papers)Joan Palou (16 shared papers)Maximilian Burger (14 shared papers)Nigel C. Cowan (16 shared papers)
- Journals
- European Urology (49 papers)Histopathology (33 papers)World Journal of Urology (28 papers)Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (25 papers)European Urology Oncology (17 papers)
- Partner nations
- FranceUnited StatesAustria
In The Last Decade
Éva Compérat
473 papers receiving 28.7k citations
Éva Compérat's Hit Papers
Peers
Comparison fields: 5 of 147
- Surgery 16.9k
- Pulmonary and Respiratory Medicine 6.6k
- Cancer Research 1.3k
- Oncology 2.1k
- Urology 532
Countries citing papers authored by Éva Compérat
This map shows the geographic impact of Éva Compérat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éva Compérat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éva Compérat more than expected).
Fields of papers citing papers by Éva Compérat
This network shows the impact of papers produced by Éva Compérat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éva Compérat. The network helps show where Éva Compérat may publish in the future.
Co-authors
The 25 scholars most cited alongside Éva Compérat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 498 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016 Hit paper breakdown → | 2016 | 1690 |
| 2 | European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines Hit paper breakdown → | 2020 | 1487 |
| 3 | Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer Hit paper breakdown → | 2016 | 1195 |
| 4 | European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update Hit paper breakdown → | 2015 | 1158 |
| 5 | European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update Hit paper breakdown → | 2017 | 1139 |
| 6 | European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ) Hit paper breakdown → | 2021 | 1078 |
| 7 | European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update Hit paper breakdown → | 2019 | 1000 |
| 8 | EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013 Hit paper breakdown → | 2013 | 989 |
| 9 | EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines Hit paper breakdown → | 2013 | 830 |
| 10 | The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours Hit paper breakdown → | 2022 | 541 |
| 11 | EAU Guidelines on Penile Cancer: 2014 Update Hit paper breakdown → | 2014 | 455 |
| 12 | The Lancet Commission on prostate cancer: planning for the surge in cases Hit paper breakdown → | 2024 | 407 |
| 13 | Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Hit paper breakdown → | 2021 | 400 |
| 14 | European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines Hit paper breakdown → | 2023 | 378 |
| 15 | European Guidelines on Upper Tract Urothelial Carcinomas: 2013 Update Hit paper breakdown → | 2013 | 364 |
| 16 | European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update Hit paper breakdown → | 2023 | 339 |
| 17 | European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel Hit paper breakdown → | 2021 | 331 |
| 18 | 2013 | 315 | |
| 19 | Current best practice for bladder cancer: a narrative review of diagnostics and treatments Hit paper breakdown → | 2022 | 304 |
| 20 | Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors Hit paper breakdown → | 2023 | 295 |
About Éva Compérat
Éva Compérat is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Urology and Cancer Research, having authored 498 papers that have together received 29.1k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (210 papers), Prostate Cancer Diagnosis and Treatment (105 papers), Renal cell carcinoma treatment (65 papers), Prostate Cancer Treatment and Research (40 papers), Urinary and Genital Oncology Studies (23 papers), Testicular diseases and treatments (15 papers), Genital Health and Disease (12 papers) and AI in cancer detection (12 papers). The work is most often cited by research in Surgery (16.9k citations), Pulmonary and Respiratory Medicine (6.6k citations), Cancer Research (1.3k citations), Oncology (2.1k citations) and Urology (532 citations). Éva Compérat has collaborated with scholars based in France, United States and Austria. Frequent co-authors include Morgan Rouprêt A, Shahrokh François Shariat, Bas W.G. van Rhijn, Richard J Sylvester, Marek Babjuk, Joan Palou, Maximilian Burger, Nigel C. Cowan, Richard E. Zigeuner and Virginia Hernández. Their work appears in journals such as European Urology, Histopathology, World Journal of Urology, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin and European Urology Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.